Effects of deflazacort on left ventricular function in patients with Duchenne muscular dystrophy

Am J Cardiol. 2003 Mar 15;91(6):769-72. doi: 10.1016/s0002-9149(02)03429-x.

Authors

Candice K Silversides¹, Gary D Webb, Vivien A Harris, Douglas W Biggar

Affiliation

¹ Toronto Congenital Cardiac Centre for Adults, Toronto General Hospital, University of Toronto, Toronto, Ontario, Canada.

PMID: 12633823
DOI: 10.1016/s0002-9149(02)03429-x

No abstract available

Publication types

Clinical Trial

MeSH terms

Adolescent
Anti-Inflammatory Agents / pharmacology*
Anti-Inflammatory Agents / therapeutic use*
Child
Cohort Studies
Echocardiography
Electrocardiography
Follow-Up Studies
Humans
Male
Muscle, Skeletal / drug effects
Muscle, Skeletal / physiopathology
Muscular Dystrophy, Duchenne / complications*
Muscular Dystrophy, Duchenne / drug therapy*
Muscular Dystrophy, Duchenne / physiopathology
Pregnenediones / pharmacology*
Pregnenediones / therapeutic use*
Retrospective Studies
Ventricular Dysfunction, Left / drug therapy*
Ventricular Dysfunction, Left / etiology*
Ventricular Dysfunction, Left / physiopathology
Ventricular Function, Left / drug effects*
Ventricular Function, Left / physiology

Substances

Anti-Inflammatory Agents
Pregnenediones
deflazacort